Article
Woman being measured around their waistlineWoman being measured around their waistline

GLP-1 Ingredient and Supply Chain Solutions for Health and Nutrition 

Exploring GLP-1 ingredients, formulations, and supply chain solutions for pharmaceuticals, nutraceuticals, food, and beverage manufacturers  

GLP‑1 receptor agonist (RA) therapies are reshaping both medicine and nutrition, but the implications for pharmaceutical teams and food brands are fundamentally different. GLP-1 medications were originally developed to regulate blood sugar levels in people with diabetes, but are now widely used for weight management, appetite control, and metabolic health. These qualities have created significant ripple effects that extend beyond the pharmaceutical industry.

As their popularity grows, GLP-1 therapies are influencing not only medical and weight outcomes but also consumer behavior, food choices, ingredient demand, and product innovation across multiple industries. For pharmaceuticals, nutraceuticals, and food and beverage manufacturers, understanding these consumer shifts is essential to your brand's growth and market share.

Explore where it matters most for your business: 

How GLP-1 therapies are reshaping health, nutrition and consumer demand 

GLP-1 agonist medications are transforming the landscape of health and nutrition by offering a comprehensive approach to managing conditions like type 2 diabetes and obesity, two of the most significant public health concerns worldwide. In a recent study it is estimated that approximately 25 million Americans will be on GLP-1 therapies by 2030, up from 10 million in just 20251, with global demand to continue to rise sharply alongside1. The market for GLP-1 analogues is projected to reach $471.1 billion by 2032, growing at an 8-year CAGR of 33.2%. While faster growth rates are forecasted in European and Middle Eastern markets, North America is expected to represent nearly 89% of global GLP-1 RA consumption by 20322. 

What makes this movement different from anything we’ve seen previously in the health sector is the cross‑industry impact of GLP‑1 medications. The GLP-1 era is driving a sustained, global behavioral shift and reshaping eating patterns, nutritional demands, and product expectations, which are expected to continue evolving for years to come.

glp-1 medication applicatorglp-1 medication applicator

Meeting the ingredient and supply chain challenges of GLP-1 growth 

Navigating the GLP-1 market requires more than understanding today’s consumer trends. It requires access to the right ingredients, produced at the highest standards, supported by a reliable global and domestic supply chain. 

With one of the world’s most diverse ingredient portfolios combined with a world-leading supply chain and distribution network, Ingredients + Specialties from Univar Solutions supports pharmaceutical, nutraceutical, and food and beverage manufacturers as they tailor products to the GLP-1 user market.

End-to-end ingredient solutions for GLP-1 markets

Whether you are tackling reformulation, supply chain, or sourcing challenges, we have the experience and logistical infrastructure to keep you moving forward in the competitive GLP-1 market and complementary markets. 

Food, beverage, and nutraceutical solutions to nourish the unique needs of GLP-1 RA users:   

The shifts in consumer demand and buying habits in the food and beverage markets due to GLP-1 therapies have been profound. As appetite suppression and portion control become common, brands are rethinking everything from portion size to formulation and packaging. 
 

Many food and beverage producers are adapting to the needs of GLP-1 consumers with products that: 

  • Deliver high fiber and protein

  • Enhance satiety and gut health

  • Support balanced nutrition with vitamins and minerals

  • Use healthy fats and low-glycemic sweeteners 

Products formulated for GLP-1 users focus on pre-portioned, nutrient dense nutrition that supports appetite regulation and sustained health benefits.  

GLP-1 companion products require ingredients that deliver high nutrient density and support satiety, digestibility, taste, and texture. Our ingredient portfolio that can help satisfy requirements includes: 

  • Select active nutraceutical ingredients (ANIs)

  • Botanicals and phytoactives

  • Minerals

  • Phospholipids

  • Prebiotic and dietary fibers

  • Proteins

  • Sweeteners

  • Vitamins

Pharmaceutical and nutraceutical solutions for the production of GLP-1 RA medications, supplements, and support products:

In the pharmaceutical sector, the demand for GLP-1 RA medications has led to significant investment in R&D, driving innovation in delivery formats, and resulting in intense competition.

Manufacturers are focused on:

  • Longer-acting formulations
  • Consumer-friendly dosing formats
  • Improved stability, scalability, and supply reliability

At the same time, nutraceutical companies are developing complementary supplements designed to support GLP-1 users, addressing nutritional gaps, digestive health, and metabolic support. 

Whether in pharmaceuticals or nutraceuticals, success hinges on high-quality, compliant, and reliable ingredient sourcing, including: 

  • Select active pharmaceutical ingredients (APIs)

  • Select active nutraceutical ingredients (ANIs)

  • Excipients

  • Solvents

  • Bioprocessing ingredients  

Lorem ipsum dolor sit amet, consectetur adipiscing elit

imperdiet proin fermentum leo vel orci porta non pulvinar neque laoreet suspendisse interdum consectetur libero id faucibus nisl tincidunt eget nullam non nisi est sit amet facilisis magna etiam tempor orci eu lobortis elementum nibh tellus molestie nunc non blandit massa enim nec dui nunc mattis enim ut tellus elementum sagittis vitae et leo duis ut diam quam nulla porttitor massa id neque aliquam vestibulum morbi blandit cursus risus at ultrices mi tempus imperdiet nulla malesuada pellentesque elit eget gravida cum sociis natoque penatibus et magnis dis parturient montes nascetur ridiculus mus mauris vitae ultricies leo integer malesuada nunc vel risus commodo viverra maecenas accumsan lacus vel facilisis volutpat est velit egestas dui id ornare arcu odio ut sem nulla pharetra diam sit amet nisl suscipit adipiscing bibendum est ultricies integer quis auctor elit sed vulputate mi sit amet mauris commodo quis imperdiet massa tincidunt nunc pulvinar sapien et ligula ullamcorper malesuada 

“Lacus eros, suscipit at laoreet iaculis, ornare vitae leo. Aenean volutpat risus diam, nec fermentum magna blandit a. Nam mollis faucibus ante eu faucibus. Ut consequat sed nisl vel condimentum.”

Lorem ipsum dolor sit amet, consectetur adipiscing elit

imperdiet proin fermentum leo vel orci porta non pulvinar neque laoreet suspendisse interdum consectetur libero id faucibus nisl tincidunt eget nullam non nisi est sit amet facilisis magna etiam tempor orci eu lobortis elementum nibh tellus molestie nunc non blandit massa enim nec dui nunc mattis enim ut tellus elementum sagittis vitae et leo duis ut diam quam nulla porttitor massa id neque aliquam vestibulum morbi blandit cursus risus at ultrices mi tempus imperdiet nulla malesuada pellentesque elit eget gravida cum sociis natoque penatibus et magnis dis parturient montes nascetur ridiculus mus mauris vitae ultricies leo integer malesuada nunc vel risus commodo viverra maecenas accumsan lacus vel facilisis volutpat est velit egestas dui id ornare arcu odio ut sem nulla pharetra diam sit amet nisl suscipit adipiscing bibendum est ultricies integer quis auctor elit sed vulputate mi sit amet mauris commodo quis imperdiet massa tincidunt nunc pulvinar sapien et ligula ullamcorper malesuada 

Customer value
  • Aliquam lacus eros, suscipit at laoreet iaculis, ornare vitae leo.
  • Aenean volutpat risus diam, nec fermentum magna blandit a.
  • Nam mollis faucibus ante eu faucibus. Ut consequat sed nisl vel condimentum.
  • Praesent nec lacus nisl. Ut ac tellus nisi.
  • Mollis faucibus ante eu faucibus. Ut consequat sed nisl vel
Customer value
  • Aliquam lacus eros, suscipit at laoreet iaculis, ornare vitae leo.
  • Aenean volutpat risus diam, nec fermentum magna blandit a.
  • Nam mollis faucibus ante eu faucibus. Ut consequat sed nisl vel condimentum.
  • Praesent nec lacus nisl. Ut ac tellus nisi.
  • Mollis faucibus ante eu faucibus. Ut consequat sed nisl vel
Customer value
  • Aliquam lacus eros, suscipit at laoreet iaculis, ornare vitae leo.
  • Aenean volutpat risus diam, nec fermentum magna blandit a.
  • Nam mollis faucibus ante eu faucibus. Ut consequat sed nisl vel condimentum.
  • Praesent nec lacus nisl. Ut ac tellus nisi.
  • Mollis faucibus ante eu faucibus. Ut consequat sed nisl vel

Lorem ipsum dolor sit amet, consectetur adipiscing elit

imperdiet proin fermentum leo vel orci porta non pulvinar neque laoreet suspendisse interdum consectetur libero id faucibus nisl tincidunt eget nullam non nisi est sit amet facilisis magna etiam tempor orci eu lobortis elementum nibh tellus molestie nunc non blandit massa enim nec dui nunc mattis enim ut tellus elementum sagittis vitae et leo duis ut diam quam nulla porttitor massa id neque aliquam vestibulum morbi blandit cursus risus at ultrices mi tempus imperdiet nulla malesuada pellentesque elit eget gravida cum sociis natoque penatibus et magnis dis parturient montes nascetur ridiculus mus mauris vitae ultricies leo integer malesuada nunc vel risus commodo viverra maecenas accumsan lacus vel facilisis volutpat est velit egestas dui id ornare arcu odio ut sem nulla pharetra diam sit amet nisl suscipit adipiscing bibendum est ultricies integer quis auctor elit sed vulputate mi sit amet mauris commodo quis imperdiet massa tincidunt nunc pulvinar sapien et ligula ullamcorper malesuada 

imperdiet proin fermentum leo vel orci porta 

imperdiet proin fermentum leo vel orci porta non pulvinar neque laoreet suspendisse interdum consectetur libero id faucibus nisl tincidunt eget nullam non nisi est sit amet facilisis magna etiam tempor orci eu lobortis elementum nibh tellus molestie nunc non blandit 


Share this post!


References
  1. JP Morgan “How demand for (and supply of) weight loss drugs is playing out in 2026” Feb 2026
  2. Newswire “GLP-1 Analogues Market Forecast: USD 471.1 Billion by 2032 with a 33.2% CAGR” July 2024

You may also like